Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13
作者:Mariangela Agamennone、Dmitry S. Belov、Antonio Laghezza、Vladimir N. Ivanov、Anton M. Novoselov、Ivan A. Andreev、Nina K. Ratmanova、Andrea Altieri、Paolo Tortorella、Alexander V. Kurkin
DOI:10.1002/cmdc.201600266
日期:2016.9.6
Matrix metalloproteinases (MMPs) are well-established targets for several pathologies. In particular, MMP-2 and MMP-13 play a prominent role in cancer progression. In this study, a structure-based screening campaign was applied to prioritize metalloproteinase-oriented fragments. This computational model was applied to a representative fragment set from the publically available EDASA Scientific compound
基质金属蛋白酶(MMPs)是几种疾病的公认目标。特别地,MMP-2和MMP-13在癌症进展中起重要作用。在这项研究中,基于结构的筛选活动被应用于优先针对金属蛋白酶的片段。该计算模型被应用于来自公共可得的EDASA Scientific化合物库的代表性片段集。对这些片段进行优先排序,并在生物学分析中测试排名最高的匹配项以验证模型。两个支架在测定中显示出一致的活性,而基于伊斯汀的化合物是最令人感兴趣的。这些后面的片段作为设计和实现新型MMP抑制剂的工具具有巨大的潜力。除了其微摩尔活性之外,